Keppra
Elderly
Nasim TabriziPhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 81/ 100
Competitive context
4 Active assets in the Elderly cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin Fudan University | Phase 1/2 | CC |
Cyclophosphamide The Second Hospital of Shandong University | Phase 1/2 | CC |
FILGRASTIM The Second Hospital of Shandong University | Phase 1/2 | CC |
FLUOROURACILUM Azienda Unita Sanitaria Locale di Piacenza | D | |
Irinotecan Azienda Unita Sanitaria Locale di Piacenza | D |
View all 11 →
Same molecule, other indications
Keppra is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →